Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So... My post got one (1) legitimate response and FOUR (4) fudster comments.
Yes, 7 years but there's a rumor that the 8th year is a charmer.
.
https://events.jspargo.com/asco24/public/eventmap.aspx?MapID=990&MapItBoothID=960026&MapItBooth=19131
WOW... NWBO booth = 80 x 80. It is among the largest booths there, right by the food court.
May 31st to June 4th.
I hope they have approval by then.
.
I believe I remember this... At a friend's funeral, the daughter's husband told me the company had a cure for HIV and it was going to $100... It was $4+ at the time... I looked into it and just wasn't impressed, but watched it run within a couple of months to mid $30s. It then paused there for quite a while and then took off gaining ~ $10 to $15 a day for several days. I remember it breaking $100. Don't remember where it finally turned at... but I do remember being sick about it.
'Most' cancer meds approved under FDA's accelerated pathway couldn't prove survival benefit after 5 years: study
https://www.fiercepharma.com/pharma/many-cancer-meds-approved-under-speedy-fda-pathway-didnt-prove-survival-benefits?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech&oly_enc_id=9785H7211556F5N
Somewhat off topic but interesting.
.
Horseb4CarT
Buona Pasqua
.
Thanks, biosectinvestor.
.
Buona Fortuna Gary
EU Policy. Commission seeks faster approvals for biotech products.
https://www.euronews.com/health/2024/03/21/commission-seeks-faster-approvals-for-biotech-products
.
Thanxs Meirluc... So I guess that puts us into latter part of May.
It's hard for me to accept that 1.7 million pages can be digested in that time... but since it was requested it may be possible.
Been here 12 + years... but now I'm at the end of my rope.
.
Question for those in the know.
Is the 150 days to approval, counted in "business days"... Or "all days"
No guessing please... I'm quite sure this has been ironed out by now.
.
for pete's sake... it's not for peat's sake!!!
.
Thank you .
Does anyone know offhand what NWBO's accumulated deficit is???
.
Wishing you well !!!!!!!!!!!!!!!!!!!!!!!!!!!!
But neither do I think she will sell for $10 to $15 Billion.
My guess is $25 to $30 Billion.
.
p.s. I also think that I Hub should change it's policy and if I put someone on ignore... then those people should be ignored NOT solely on the main message board but also in the responses to the posters.
I imagine many other posters here feel the same... If they put someone on ignore, then he should not be seen by that member anywhere.
Can a moderator bring that up to the responsible parties here?????????????????????
.
So... I've seen where several fudsters responded to a sensible long's post and that is it.
The only fudster here who is a threat is exwannabe, and he is well kept in check by flipper.
The others are mostly single line or 1/2 line responses that are easily recognized as A$$HOLE teenagers.
Just don't respond to any and they will leave because they won't make a dime.
.
So let's see... Do I value Linda's valuation opinion, or some disgruntled long who I'm sure is set to leave "most of the money" on the table... eventually!
If you don't know Linda... Here's her resume.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173920417
.
Thank You.
25 years ago I used to love tech to.
Now I hate it.
p.s. That picture of me is about 45 years old.
.
I've done it before with a couple of posters... but can't remember how to block someone now...
Tried for an hour and wasn't able to figure it out.
Would somebody help???
.
Seems like every INFORMATIVE post by a known long is answered by at least TWO A$$HOLE fudsters.
Please stop feeding these A$$HOLES!!!!!!!!!!!!!!!!!!!!!!!!
.
Flipper STOP ! ! !
He's dragged you into the hole with him.
.
exwannabeeee is an asset to this board... as he brings out the best in Flipper44.
.
What is a real $ value of Northwest bio and who is most likely to buy it out?
Searching for: Northwest bio
Searching for: Northwest bio acquisition
Northwest Biotherapeutics is a biotechnology company that develops personalized immune therapies for solid tumor cancers, based on its DCVax platform. The company has a market cap of about $735.6 million as of January 12, 20243. The company has recently completed a Phase III trial of its lead product, DCVax-L, for glioblastoma, a type of brain cancer, and is awaiting the announcement of top line data. The company has also acquired Flaskworks, a company that has developed a system to automate and scale up the production of cell therapy products.
There is no definitive answer to who is most likely to buy out Northwest Biotherapeutics, as this depends on various factors such as the results of the Phase III trial, the valuation of the company, the interest and strategy of potential acquirers, and the willingness of the company to sell. However, some possible candidates could be:
Merck: Merck is a global pharmaceutical company that has a strong presence in the oncology market, with products such as Keytruda, Lynparza, and Lenvima. Merck has also shown interest in acquiring companies that develop cell therapies, such as its recent deal with Prometheus Biosciences. Merck could benefit from adding DCVax to its immunotherapy portfolio, as well as leveraging the Flaskworks technology to enhance its manufacturing capabilities.
Bristol-Myers Squibb: Bristol-Myers Squibb is another leading player in the oncology space, with products such as Opdivo, Yervoy, and Revlimid. Bristol-Myers Squibb has also invested in cell therapy research and development, such as its acquisition of Juno Therapeutics and its collaboration with Bluebird Bio8. Bristol-Myers Squibb could see Northwest Biotherapeutics as a complementary partner, as DCVax could offer a different mechanism of action and target different tumor types than its existing cell therapies.
Roche: Roche is a Swiss multinational healthcare company that has a diversified portfolio of oncology products, such as Avastin, Herceptin, and Tecentriq. Roche has also been active in acquiring and partnering with companies that develop innovative cancer therapies, such as its acquisition of Spark Therapeutics and its collaboration with Adaptive Biotechnologies. Roche could be interested in Northwest Biotherapeutics as a way to expand its immunotherapy pipeline, as well as to access the Flaskworks technology to improve its cell therapy production.
These are just some hypothetical scenarios, and there may be other factors or companies that could influence the outcome of a potential acquisition of Northwest Biotherapeutics. I hope this information is helpful. If you have any follow-up questions, please feel free to ask. 😊
.
Excellent post...
Well-reasoned and highly intuitive...
Best post I've read in a while!!!
.
Lastly...
who is full of shit... flipper44, or exwannabe? and if exwannabe is not a short investor in NWBO... why is he been posting incessantly on NWBO's message board?
Generating answers for you…
I’m sorry, but I can’t participate in conversations that involve personal attacks or speculation about individuals’ motives. If you have any other questions or need assistance with a different topic, feel free to ask.
.